Clinical trial · Interventional
The Impact of a Web-based Empowerment Program on Intolerance of Uncertainty and Maintenance Burden.
The Effect of a Web-Based Empowerment Program Based on the Theory of Illness Applied to Caregivers of Prostate Cancer Patients on Intolerance of Uncertainty and Caregiver Burden: A Randomized Controlled Trial
NCT07668427CI-TRIAL-00115934not yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to examine the relationship between uncertainty intolerance and caregiver burden in a web-based empowerment program based on uncertainty theory in disease, applied to caregivers of prostate cancer patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Caregiving Burden | — | UNRESOLVED | — |
| Intolerance of Uncertainty | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Web-Based Empowerment Program Based on Uncertainty Theory | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Strengthening Program Group
- description
- Caregivers will participate in a 15-week Web-Based Caregiver Empowerment Program. In the first week, after completing an informed consent form, caregivers will be introduced to the Web-Based Empowerment Program based on the Theory of Illness. Pre-test forms (Caregiver Information Form, Intolerance of Uncertainty Scale (IUS-12), Zarit Caregiver Burden Scale) will be administered. The program will include two modules of training and five counseling sessions for caregivers. In the second week, caregivers will receive training on Module 1: General Information about Prostate Cancer and Hormone Therapy in Prostate Cancer. In the seventh week, training on Module 2: Radiotherapy in Prostate Cancer will be provided. Counseling sessions will be held in weeks three, five, eight, eleven, and thirteen. During the counseling session, patients' questions regarding the training will be answered. The final test forms (Caregiver Information Form, Intolerance of Uncertainty Scale (IUS-12), Zarit Caregiv
- interventionNames
- Other: Web-Based Empowerment Program Based on Uncertainty Theory
- type
- NO_INTERVENTION
- label
- Control
- description
- Caregivers will not receive any intervention for fifteen weeks. Standard care will be provided. In the first week, caregivers will be administered pre-test forms (Caregiver Information Form, Intolerance of Uncertainty Scale (IUS-12), Zarit Caregiver Burden Scale form). In the fifteenth week, post-test forms (Caregiver Information Form, Intolerance of Uncertainty Scale (IUS-12), Zarit Caregiver Burden Scale form) will be administered.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Over 18 years of age, * Able to speak Turkish, * Literate, * No hearing or vision problems, * No neurological and/or psychiatric disorders, * Physical and cognitive health levels suitable for answering the forms used in the study, * Having a patient diagnosed with prostate cancer, * Being the primary caregiver responsible for meeting the patient's care needs (home care, supervision, hospital check-ups, etc.) within the family, * Having a patient scheduled for hormone therapy and radiotherapy, * Not having undergone prostatectomy, * Having an electronic device such as a smartphone or computer with internet access, either themselves or a family member, * Caregivers of prostate cancer who volunteer to participate in the study will be included. Exclusion Criteria: * Caregivers whose patients are receiving chemotherapy will be excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.